NO180749C - Analogifremgangsmåte for fremstilling av terapeutisk aktive benzimidazolsubstituerte derivater - Google Patents
Analogifremgangsmåte for fremstilling av terapeutisk aktive benzimidazolsubstituerte derivaterInfo
- Publication number
- NO180749C NO180749C NO914263A NO914263A NO180749C NO 180749 C NO180749 C NO 180749C NO 914263 A NO914263 A NO 914263A NO 914263 A NO914263 A NO 914263A NO 180749 C NO180749 C NO 180749C
- Authority
- NO
- Norway
- Prior art keywords
- therapeutically active
- substituted derivatives
- analogous process
- preparing therapeutically
- benzimidazole substituted
- Prior art date
Links
- 125000003785 benzimidazolyl group Chemical group N1=C(NC2=C1C=CC=C2)* 0.000 title 1
- 238000004519 manufacturing process Methods 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/10—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
- C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
- C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/415—1,2-Diazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
- C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing three or more hetero rings
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Cardiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Heart & Thoracic Surgery (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US60663190A | 1990-10-31 | 1990-10-31 |
Publications (4)
| Publication Number | Publication Date |
|---|---|
| NO914263D0 NO914263D0 (no) | 1991-10-30 |
| NO914263L NO914263L (no) | 1992-05-04 |
| NO180749B NO180749B (no) | 1997-03-03 |
| NO180749C true NO180749C (no) | 1997-06-11 |
Family
ID=24428787
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO914263A NO180749C (no) | 1990-10-31 | 1991-10-30 | Analogifremgangsmåte for fremstilling av terapeutisk aktive benzimidazolsubstituerte derivater |
Country Status (23)
| Country | Link |
|---|---|
| EP (1) | EP0488532A1 (cs) |
| JP (1) | JPH0592969A (cs) |
| KR (1) | KR920008032A (cs) |
| CN (1) | CN1061224A (cs) |
| AU (1) | AU650294B2 (cs) |
| CA (1) | CA2054594A1 (cs) |
| CS (1) | CS330591A3 (cs) |
| EG (1) | EG19826A (cs) |
| FI (1) | FI915148A7 (cs) |
| HU (1) | HU214575B (cs) |
| IE (1) | IE913785A1 (cs) |
| IL (1) | IL99917A0 (cs) |
| MX (1) | MX9101873A (cs) |
| MY (1) | MY108611A (cs) |
| NO (1) | NO180749C (cs) |
| NZ (1) | NZ240383A (cs) |
| PH (1) | PH31175A (cs) |
| PL (1) | PL168902B1 (cs) |
| PT (1) | PT99404A (cs) |
| RO (1) | RO109735B1 (cs) |
| RU (1) | RU2111208C1 (cs) |
| YU (1) | YU173791A (cs) |
| ZA (1) | ZA918688B (cs) |
Families Citing this family (30)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PT95899A (pt) * | 1989-11-17 | 1991-09-13 | Glaxo Group Ltd | Processo para a preparacao de derivados indole |
| GB9113626D0 (en) * | 1991-06-25 | 1991-08-14 | Ici Plc | Heterocyclic compounds |
| GB9113628D0 (en) * | 1991-06-25 | 1991-08-14 | Ici Plc | Heterocyclic derivatives |
| EP0602246A4 (en) * | 1992-03-25 | 1995-07-05 | Green Cross Corp | Isoindazole derivatives. |
| DK40192D0 (da) * | 1992-03-26 | 1992-03-26 | Neurosearch As | Imidazolforbindelser, deres fremstilling og anvendelse |
| US5538973A (en) * | 1992-03-27 | 1996-07-23 | Kyoto Pharmaceutical Industries, Ltd. | Imidazole derivative, pharmaceutical use thereof, and intermediate therefor |
| EP0597112A4 (en) * | 1992-03-27 | 1994-06-22 | Kyoto Pharma Ind | Novel imidazole derivative, pharmaceutical use thereof, and intermediate therefor. |
| GB9218449D0 (en) | 1992-08-29 | 1992-10-14 | Boots Co Plc | Therapeutic agents |
| AU675484B2 (en) * | 1993-03-24 | 1997-02-06 | Neurosearch A/S | Benzimidazole compounds, their use and preparation |
| SE9903028D0 (sv) | 1999-08-27 | 1999-08-27 | Astra Ab | New use |
| BRPI0512252A (pt) | 2004-06-18 | 2008-02-19 | Biolipox Ab | composto ou um sal farmaceuticamente aceitável do mesmo, formulação farmacêutica, uso de um composto, método de tratamento de uma doença, produto combinado, e, processo para a preparação de um composto |
| US7868037B2 (en) | 2004-07-14 | 2011-01-11 | Ptc Therapeutics, Inc. | Methods for treating hepatitis C |
| US7781478B2 (en) | 2004-07-14 | 2010-08-24 | Ptc Therapeutics, Inc. | Methods for treating hepatitis C |
| US7772271B2 (en) | 2004-07-14 | 2010-08-10 | Ptc Therapeutics, Inc. | Methods for treating hepatitis C |
| EA200700243A1 (ru) | 2004-07-14 | 2007-08-31 | ПиТиСи ТЕРАПЬЮТИКС, ИНК. | Способы лечения гепатита с |
| EP1781289A1 (en) | 2004-07-22 | 2007-05-09 | PTC Therapeutics, Inc. | Thienopyridines for treating hepatitis c |
| WO2006077366A1 (en) | 2005-01-19 | 2006-07-27 | Biolipox Ab | Indoles useful in the treatment of inflammation |
| US8969514B2 (en) | 2007-06-04 | 2015-03-03 | Synergy Pharmaceuticals, Inc. | Agonists of guanylate cyclase useful for the treatment of hypercholesterolemia, atherosclerosis, coronary heart disease, gallstone, obesity and other cardiovascular diseases |
| WO2008151257A2 (en) | 2007-06-04 | 2008-12-11 | Synergy Pharmaceuticals Inc. | Agonists of guanylate cyclase useful for the treatment of gastrointestinal disorders, inflammation, cancer and other disorders |
| ES2627848T3 (es) | 2008-06-04 | 2017-07-31 | Synergy Pharmaceuticals Inc. | Agonistas de la guanilato ciclasa útiles para el tratamiento de trastornos gastrointestinales, inflamación, cáncer y otros trastornos |
| ES2624828T3 (es) | 2008-07-16 | 2017-07-17 | Synergy Pharmaceuticals Inc. | Agonistas de la guanilato ciclasa útiles para el tratamiento de trastornos gastrointestinales, inflamación, cáncer y otros |
| US9616097B2 (en) | 2010-09-15 | 2017-04-11 | Synergy Pharmaceuticals, Inc. | Formulations of guanylate cyclase C agonists and methods of use |
| CN103965167A (zh) * | 2013-01-29 | 2014-08-06 | 通化济达医药有限公司 | 咪唑羧酸衍生物 |
| US9708367B2 (en) | 2013-03-15 | 2017-07-18 | Synergy Pharmaceuticals, Inc. | Agonists of guanylate cyclase and their uses |
| EP2968439A2 (en) | 2013-03-15 | 2016-01-20 | Synergy Pharmaceuticals Inc. | Compositions useful for the treatment of gastrointestinal disorders |
| PL3004138T3 (pl) | 2013-06-05 | 2024-07-29 | Bausch Health Ireland Limited | Ultra-oczyszczeni agoniści peptydowi cyklazy guanylanowej C, sposób ich uzyskiwania i ich zastosowanie |
| CN106397414A (zh) * | 2015-08-14 | 2017-02-15 | 陈志龙 | 杂螺环酮吲哚衍生物的一种制备方法 |
| JP2024506858A (ja) | 2021-02-02 | 2024-02-15 | リミナル・バイオサイエンシーズ・リミテッド | Ｇｐｒ８４アンタゴニストおよびその使用 |
| KR20230153387A (ko) | 2021-02-02 | 2023-11-06 | 리미널 바이오사이언시스 리미티드 | Gpr84 길항제 및 이의 용도 |
| CN113999204B (zh) * | 2021-11-08 | 2023-09-05 | 常州大学 | 一种非手性咪唑型离子化合物及其制备方法和应用 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4880804A (en) * | 1988-01-07 | 1989-11-14 | E. I. Du Pont De Nemours And Company | Angiotensin II receptor blocking benzimidazoles |
| US4826862A (en) * | 1988-02-12 | 1989-05-02 | Janssen Pharmaceutica, N.V. | Anthelminthic [(5(6) (1H-azole-1-ylmethyl)benzimidazole]carbamates |
| GB8820231D0 (en) * | 1988-08-25 | 1988-09-28 | Fujisawa Pharmaceutical Co | New benzazole compounds processes for preparation thereof & pharmaceutical composition comprising same |
| PT95899A (pt) * | 1989-11-17 | 1991-09-13 | Glaxo Group Ltd | Processo para a preparacao de derivados indole |
| DE4010797A1 (de) * | 1990-04-04 | 1991-10-10 | Hoechst Ag | Substituierte azole, verfahren zu deren herstellung, diese enthaltende mittel und deren verwendung |
-
1991
- 1991-10-23 PH PH43330A patent/PH31175A/en unknown
- 1991-10-29 NZ NZ240383A patent/NZ240383A/en unknown
- 1991-10-30 IE IE378591A patent/IE913785A1/en not_active Application Discontinuation
- 1991-10-30 HU HU913418A patent/HU214575B/hu not_active IP Right Cessation
- 1991-10-30 RU SU5010095A patent/RU2111208C1/ru active
- 1991-10-30 NO NO914263A patent/NO180749C/no unknown
- 1991-10-30 EG EG66391A patent/EG19826A/xx active
- 1991-10-30 RO RO148651A patent/RO109735B1/ro unknown
- 1991-10-31 IL IL99917A patent/IL99917A0/xx unknown
- 1991-10-31 EP EP91310076A patent/EP0488532A1/en not_active Ceased
- 1991-10-31 MY MYPI9102106 patent/MY108611A/xx unknown
- 1991-10-31 KR KR1019910019254A patent/KR920008032A/ko not_active Abandoned
- 1991-10-31 YU YU173791A patent/YU173791A/sh unknown
- 1991-10-31 PT PT99404A patent/PT99404A/pt not_active Application Discontinuation
- 1991-10-31 AU AU86910/91A patent/AU650294B2/en not_active Ceased
- 1991-10-31 JP JP3286584A patent/JPH0592969A/ja active Pending
- 1991-10-31 MX MX9101873A patent/MX9101873A/es not_active IP Right Cessation
- 1991-10-31 PL PL91292249A patent/PL168902B1/pl unknown
- 1991-10-31 CN CN91110565A patent/CN1061224A/zh active Pending
- 1991-10-31 ZA ZA918688A patent/ZA918688B/xx unknown
- 1991-10-31 CA CA002054594A patent/CA2054594A1/en not_active Abandoned
- 1991-10-31 CS CS913305A patent/CS330591A3/cs unknown
- 1991-10-31 FI FI915148A patent/FI915148A7/fi unknown
Also Published As
| Publication number | Publication date |
|---|---|
| NO180749B (no) | 1997-03-03 |
| IL99917A0 (en) | 1992-08-18 |
| HUT59677A (en) | 1992-06-29 |
| MX9101873A (es) | 1992-06-05 |
| FI915148A0 (fi) | 1991-10-31 |
| PL168902B1 (pl) | 1996-05-31 |
| HU214575B (hu) | 1998-04-28 |
| JPH0592969A (ja) | 1993-04-16 |
| RU2111208C1 (ru) | 1998-05-20 |
| PH31175A (en) | 1998-03-20 |
| EG19826A (en) | 1996-03-31 |
| NZ240383A (en) | 1994-12-22 |
| YU173791A (sh) | 1994-01-20 |
| PT99404A (pt) | 1992-09-30 |
| NO914263D0 (no) | 1991-10-30 |
| HU913418D0 (en) | 1992-01-28 |
| FI915148A7 (fi) | 1992-05-01 |
| KR920008032A (ko) | 1992-05-27 |
| CS330591A3 (en) | 1992-06-17 |
| RO109735B1 (ro) | 1995-05-30 |
| NO914263L (no) | 1992-05-04 |
| CN1061224A (zh) | 1992-05-20 |
| IE913785A1 (en) | 1992-05-22 |
| EP0488532A1 (en) | 1992-06-03 |
| AU650294B2 (en) | 1994-06-16 |
| PL292249A1 (en) | 1992-07-13 |
| CA2054594A1 (en) | 1992-05-01 |
| MY108611A (en) | 1996-10-31 |
| ZA918688B (en) | 1992-08-26 |
| AU8691091A (en) | 1992-05-07 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO176759C (no) | Analogifremgangsmåte for fremstilling av terapeutisk aktive 3-substituerte-2-oksindol-derivater | |
| NO179283C (no) | Analogifremgangsmåte for fremstilling av terapeutisk aktive substituerte azoler | |
| FI890652A7 (fi) | Menetelmä terapeuttisesti aktiivisten substituoitujen indolyylipyrrolijohdannaisten valmistamiseksi | |
| NO180586C (no) | Analogifremgangsmåte for fremstilling av terapeutisk aktive substituerte imidazoler | |
| FI91152B (fi) | Menetelmä terapeuttisesti aktiivisten bentsimidatsolijohdannaisten valmistamiseksi | |
| NO179448C (no) | Analogifremgangsmåte for fremstilling av terapeutisk aktive forbindelser | |
| FI923527L (fi) | Menetelmä terapeuttisesti käyttökelpoisten 3-piperidino-4-hydroksikromaanijohdannaisten valmistamiseksi | |
| FI921473L (fi) | Menetelmä terapeuttisesti käyttökelpoisten bentsimidatsolijohdannaisten valmistamiseksi | |
| NO178543C (no) | Analogifremgangsmåte for fremstilling av terapeutisk aktive benzopyranderivater | |
| FI930150L (fi) | Menetelmä terapeuttisesti aktiivisten indolijohdannaisten valmistamiseksi | |
| FI930723A0 (fi) | Menetelmä terapeuttisesti aktiivisten tiatsolidiinijohdannaisten valmistamiseksi | |
| FI925871L (fi) | Menetelmä terapeuttisesti aktiivisten fenyyliguanidiinijohdannaisten valmistamiseksi | |
| NO174959C (no) | Analogifremgangsmåte for fremstilling av terapeutisk aktive N-aminobutyl-N-fenyl-arylamidderivater | |
| NO175429C (no) | Analogifremgangsmåte ved fremstilling av terapeutisk aktive 16-dehydro-vitamin-D3-derivater | |
| NO178967C (no) | Analogifremgangsmåte for fremstilling av terapeutisk aktive pyridazin-derivater | |
| NO176142C (no) | Analogifremgangsmåte for fremstilling av terapeutisk aktive aminoalkoksyfenylderivater | |
| NO173784C (no) | Anaslogifremgangsmaate for fremstilling av terapeutisk aktive tieno-tri-azolo-diazepinderivater | |
| FI930633A7 (fi) | Bensimidatsolijohdannaiset, menetelmä niiden valmistamiseksi ja niiden käyttö | |
| FI924642L (fi) | Menetelmä terapeuttisesti aktiivisten 3-indolyylitioasetaattijohdannaisten valmistamiseksi | |
| NO176477C (no) | Analogifremgangsmåte for fremstilling av terapeutisk aktive 2-alkoksymetylsubstituerte kromanderivater | |
| FI916058A7 (fi) | Menetelmä terapeuttisesti aktiivisten dihydrobentsofuraanikarboksamidien valmistamiseksi | |
| NO176100C (no) | Analogifremgangsmåte for fremstilling av terapeutisk aktive oksodihydropyridyl- og oksodihydropyridazinylkromanderivater | |
| NO175781C (no) | Analogifremgangsmåte for fremstilling av terapeutisk aktive tetracykliske forbindelser | |
| FI925260L (fi) | Menetelmä terapeuttisesti käyttökelpoisten 6-amino-substituoitujen oktahydro-1,7,8-indolitsiinitriolijohdannaisten valmistamiseksi | |
| FI911747L (fi) | Menetelmä terapeuttisesti aktiivisten substituoitujen aromaattisten sulfonamidijohdannaisten valmistamiseksi |